XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities    
Net Income (loss) $ 3,105 $ (1,110)
Adjustments to reconcile net income (loss) applicable to common shares to net cash flow from operating activities:    
Gain on sale of land (563) (6,615)
Gain on sale of income-producing properties (25,429) (8,840)
Depreciation and amortization 16,120 16,735
Provision for impairment of notes receivable and real estate assets 1,926 0
Amortization of deferred borrowing costs 3,705 2,360
Earnings from unconsolidated investees (256) (284)
Decrease (Increase) in assets    
Accrued interest receivable (3,260) (2,889)
Other assets (17) (1,680)
Prepaid expense (1,937) (182)
Escrow 6,074 2,858
Earnest money 1,545 235
Rent receivables (676) 444
Related party receivable 0 (1,063)
Decrease in liabilities:    
Accrued interest payable (1,752) (5,702)
Related party payables (2,492) (10,294)
Other liabilities. (9,027) (15,603)
Net cash used in operating activities (12,934) (31,630)
Cash Flow From Investing Activities:    
Proceeds from notes receivables 2,855 16,055
Origination of notes receivable (38) (10,266)
Acquisition of land held for development (7) (8,503)
Proceeds from sale of income-producing properties 73,621 41,787
Proceeds from sale of land 3,664 41,041
Proceeds from sale of investments 0 132
Investment in unconsolidated real estate entities (1,911) 3,109
Improvement of land held for development (373) (190)
Improvement of income-producing properties (6,396) (2,481)
Acquisition of non-controlling interest (77) (357)
Sale of non-controlling interest 0 (1,468)
Sale of controlling interest 50 1,147
Construction and development of new properties (327) (4,771)
Net cash provided by investing activities 71,061 75,235
Cash Flow From Financing Activities:    
Proceeds from notes payable 142,802 139,604
Recurring amortization of principal on notes payable (13,401) (18,944)
Payments on maturing notes payable (191,291) (172,225)
Stock-secured borrowings and margin debt (411) 0
Deferred financing costs (1,524) (3,521)
Distributions to non-controlling interests (179) (255)
Preferred stock dividends - Series A (1,839) (1,839)
Net cash used in financing activities (65,843) (57,180)
Net decrease in cash and cash equivalents (7,716) (13,575)
Cash and cash equivalents, beginning of period 17,141 20,312
Cash and cash equivalents, end of period 9,425 6,737
Supplemental disclosures of cash flow information:    
Cash paid for interest 22,659 32,480
Schedule of noncash investing and financing activities:    
Notes receivable received from related party $ 0 $ 9,279